Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
OTC Markets
ETFs
Canadian ETFs
US ETFs
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
News Focus
TRILLION ENERGY’S WEST AKCAKOCA WELL ENTERS PRODUCTION (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Lobe Sciences Ltd Ordinary Shares
C.LOBE
Alternate Symbol(s):
GTSIF
Healthcare
Drug Manufacturers - Major
Lobe Sciences Ltd is a technology and services company that provides real estate, financial, management, IP, and branding support for the...
development of transformational medicine. It is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:LOBE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 13, 2022 8:01am
New Press Release - Lobe Sciences Announces the Completion of cGMP Production of Clinical Supplies For Upcoming Clinical Trials
Appointment of Philip J. Young, CEO, as Board ChairmanVancouver, British Columbia--(Newsfile Corp. - October 13, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering and developing psychedelic derived...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 05, 2022 9:10am
New Press Release - Lobe Sciences Announces the Appointment of Baxter F. Phillips III to Its Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - October 5, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering and developing psychedelic derived medicines for neurologic and brain disease today announced...
read article.
Numinus Launches a Complete Psychedelic-Assisted Therapy Training Program
posted Mar 28, 2023 9:00am by
Numinus Wellness Inc.
-
|
The Certification Pathway develops core PAT skills through multi-modal teaching methods including interactive evidence and theory reviews, audio-visual design, case-based learning, experiential learning, in-person shadowing opportunities, and more. Once all course requirements in the Certification Pathway are completed, trained practitioners will receive a formal certificate from Numinus to designate competency in providing PAT using specific medicines. ...read more
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 03, 2022 5:31pm
New Press Release - Lobe Sciences Announces the Expansion of its Patent Portfolio with International Filings
Resignation of Board Chairman, Jonathan Gilbert and Shares for Debt TransactionsVancouver, British Columbia--(Newsfile Corp. - October 3, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering and developing...
read article.
(17)
•••
Unimaginatively
X
Comment by
Unimaginatively
on Sep 28, 2022 3:58pm
RE:RE:Cheap Mushroom Gem ~ $SILO Wellness @ .035¢ / share📈🤓💎
Very easily can plow through .04 no problem. Only 132 lots.
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 23, 2022 8:02am
New Press Release - Lobe Sciences Announces Incorporation of Australian Subsidiary
Vancouver, British Columbia--(Newsfile Corp. - September 23, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering and developing psychedelic derived medicines for neurologic and brain disease today announced...
read article.
(3)
•••
ApricotKernel
X
Comment by
ApricotKernel
on Sep 16, 2022 4:37pm
RE:Cheap Mushroom Gem ~ $SILO Wellness @ .035¢ / share📈🤓💎
ALL ABOARD CHOOO-CHOOO
(61)
•••
initforthemush
X
Comment by
initforthemush
on Sep 15, 2022 12:00am
RE:RE:RE:Cheap Mushroom Gem ~ $SILO Wellness @ .035¢ / share📈🤓💎
What is going on with LOBE? Hit .29 cents days ago and now about 15 cents. Bids have dropped off. I have no choice but to sell off 50% of my position for another cheaper play and that would be SILO. I
...more
(17)
•••
markovschrilovo
X
Comment by
markovschrilovo
on Sep 13, 2022 1:52pm
RE:RE:Cheap Mushroom Gem ~ $SILO Wellness @ .035¢ / share📈🤓💎
100% SILO NEXT TO BLOW !!!!
(17)
•••
Unimaginatively
X
Comment by
Unimaginatively
on Sep 08, 2022 3:25pm
RE:Cheap Mushroom Gem ~ $SILO Wellness @ .035¢ / share📈🤓💎
Thanks for this tip !!! Its been so quiet and slow for major news releases but silo looks golden for future. I add to watch list for now as no spare cash to buy it yet :-I
(17)
•••
TheCreator
X
Post by
TheCreator
on Sep 08, 2022 2:59pm
Cheap Mushroom Gem ~ $SILO Wellness @ .035¢ / share📈🤓💎
Read the latest news article by Forbes https://www.forbes.com/sites/javierhasse/2022/08/22/this-ecotourism-resort-in-jamaica-now-offers-psilocybin-microdosing-retreats-and-experiences-what-a-time-to
...more
(712)
•••
Betteryear2
X
Post by
Betteryear2
on Aug 19, 2022 4:23pm
Lobe Sciences Announces Update
Lobe Sciences Announces Update on Corporate Slide Deck Highlighting its Psilocin Compounds and Development Plans
(712)
•••
Betteryear2
X
Post by
Betteryear2
on Aug 10, 2022 5:23pm
Microdose Announces The 2nd Annual Microdose Awards
Miami, Florida--(Newsfile Corp. - August 9, 2022) - Microdose Psychedelic Insights, the leading guide to the business of psychedelics, is excited to announce the lineup of categories for the 2nd
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 07, 2022 10:24am
New Press Release - Lobe Sciences Ltd. Announces Regulatory and Clinical Development Plans For 2022 and Early 2023
Vancouver, British Columbia--(Newsfile Corp. - July 7, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBED) ("Lobe" or the "Company"), a Canadian Biotechnology company committed to discovering and developing psychedelic derived medicines today announced it has developed its initial Phase 1 study...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 21, 2022 9:17am
New Press Release - Lobe Sciences Ltd. and Clearway Global LLC Enter into a Development Agreement to Manage Lobe Sciences Ltd.'s Global Regulatory and Development Strategy and its Implementation
Vancouver, British Columbia--(Newsfile Corp. - June 21, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBED) ("Lobe" or the "Company"), a Canadian Biopsychedelics company committed to discovering and developing psychedelic inspired medicines for the improvement of neurologic, brain and mental...
read article.
(14)
•••
AllForTheMoney
X
Post by
AllForTheMoney
on Jun 17, 2022 2:13pm
🎫🤑🎬 FEELING BULLISH --- Phillip J Young
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Herald Price Sensitive
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}}
{{story.headline}}
< Previous bulletin
Next bulletin >
The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video
{{moreVideoText}}
Next Video >
Featured News Links
This Silver Producer Outperformed Peers in Q4 and Looks Strong for 2023
ESG Dynamo Scores Big Again with Record Q4 and YE 2022 Results
Well-funded Mineral Exploration Company Focused on Exploring Economically Viable Mineral Deposits
Clean Energy VS. Renewable Energy, Which is Better and Why? Download Insights Report Here